Lexagene met with the DHS to discuss the LX2 detecting airborne diseases.
LexaGene has been selected to present at the upcoming LD Micro Annual Conference in Los Angeles, CA on Tuesday, Dec 4th, 2018 at 1 PM, where the Company will introduce its technology to investors in attendance.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.